Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

Presentation TCT 2017

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

Presenter: Kurt Huber, Jamil Abdalla Saad, Antonio Gutierrez, MD

October 31, 2017

Presentation TCT 2017

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

Presenter: Kurt Huber, Jamil Abdalla Saad, Dimitrios Alexopoulos, Antonio L. Bartorelli, Bjorn Redfors, Carlos E. Uribe

October 31, 2017

Presentation TCT 2017

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD

October 31, 2017

Presentation TCT 2017

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

Presenter: Kurt Huber, Jamil Abdalla Saad, Kara Denby, MD

October 31, 2017

Presentation TCT 2017

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

Presenter: Peter C. Block, Lars Sondergaard, Maria Del Trigo, MD

October 31, 2017

Presentation TCT 2017

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD

October 31, 2017

Advertisement

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

TCT 92: Polyvascular Disease and Risk of Major Cardiovascular Events in Peripheral Artery Disease - Insights From EUCLID

TCT 91: Antithrombotic Therapy Post Transcatheter Aortic Valve Replacement in Patients With No Indication for Anticoagulation

TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials

TCT 90: HAS-BLED Score and Other Predictors of Bleeding in Catheter-Directed Thrombolysis for Pulmonary Embolism

TCT 50: Impact of Anticoagulation Therapy on Valve Hemodynamic Deterioration Following Transcatheter Aortic Valve Replacement

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content